Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Adapthealth Corp

Healthcare US AHCO

9.7USD
0.03(0.31%)

Last update at 2026-03-10T20:00:00Z

Day Range

9.589.98
LowHigh

52 Week Range

6.3715.37
LowHigh

Fundamentals

  • Previous Close 9.67
  • Market Cap1346.67M
  • Volume2680864
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA668.26M
  • Revenue TTM3248.05M
  • Revenue Per Share TTM24.28
  • Gross Profit TTM 490.83M
  • Diluted EPS TTM-5.29

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 97.90M 190.96M -70.67300M 12.53M 2.92M
Minority interest -3.81700M -1.97800M -23.59300M -14.72900M 2.87M
Net income 69.32M 156.18M -58.71800M 12.24M 2.09M
Selling general administrative 162.12M 167.50M 89.35M 56.49M 1.04M
Selling and marketing expenses - - - 12.13M -
Gross profit 417.43M 445.61M 161.23M 89.80M 60.08M
Reconciled depreciation 351.18M 258.05M 82.44M 62.57M -
Ebit 190.41M 225.60M 74.79M 29.70M -9.53295M
Ebitda 541.34M 481.83M -12.55400M 37.08M -1.23372M
Depreciation and amortization 350.93M 256.22M -87.34400M 7.38M 8.30M
Non operating income net other - 31.16M -137.24000M - -
Operating income 190.41M 225.60M 74.79M 29.70M -1.23372M
Other operating expenses 2780.18M 2228.93M 981.60M 157.69M 1.23M
Interest expense 109.41M 95.19M 41.43M 13.26M 4.15M
Tax provision 24.77M 32.81M -11.95500M 1.16M 0.83M
Interest income - - - 39.30M 4.15M
Net interest income -109.41400M -95.19500M -41.43000M -39.30449M 4.15M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 24.77M 32.81M -11.95500M 0.29M 0.83M
Total revenue 2970.59M 2454.53M 1056.39M 529.64M 345.28M
Total operating expenses 227.01M 220.00M 86.44M 44.36M 1.23M
Cost of revenue 2553.17M 2008.92M 895.16M 439.85M 285.20M
Total other income expense net -92.50900M -34.64600M -145.46300M -17.16500M 4.15M
Discontinued operations - - - - -
Net income from continuing ops 73.13M 158.15M -58.71800M -12.88511M 2.09M
Net income applicable to common shares 63.45M 156.18M -64.48100M -17.06200M 23.26M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 4619.83M 5219.59M 5250.48M 1826.26M 227.84M
Intangible assets 130.16M 162.77M 202.23M 116.06M 54.80M
Earning assets - - - - -
Other current assets 69.34M 52.14M 37.44M 37.44M 3.15M
Total liab 3153.16M 3061.83M 3183.80M 1431.51M 212.70M
Total stockholder equity 1458.45M 2157.76M 2066.69M 394.75M -73.34773M
Deferred long term liab - - - - -
Other current liab 195.16M 134.86M 153.55M 202.34M 23.27M
Common stock 0.01M 0.01M 0.01M 0.00900M 0.00724M
Capital stock 0.01M 0.01M 0.01M 0.01000M 0.00724M
Retained earnings -652.60000M 26.30M -43.02100M -91.06300M -74.78600M
Other liab - 344.00M 380.25M 209.01M 29.34M
Good will 2724.96M 3545.30M 3512.57M 1002.02M 110.36M
Other assets - 300.47M 319.29M 224.88M 34.77M
Cash 77.13M 46.27M 149.63M 99.96M 9.77M
Cash and equivalents - - - - -
Total current liabilities 537.00M 456.21M 499.81M 434.84M 52.84M
Current deferred revenue 38.57M 31.64M 31.37M 11.04M 1.42M
Net debt 2217.52M 2282.55M 2220.97M 707.03M 151.60M
Short term debt 91.76M 67.21M 66.86M 30.43M 1.66M
Short long term debt 53.37M 35.00M 20.00M 8.15M 1.72M
Short long term debt total 2294.65M 2328.82M 2370.60M 807.00M 161.37M
Other stockholder equity 2106.68M 2122.76M 2112.05M 490.21M 73.35M
Property plant equipment - 622.01M 546.34M 110.47M 63.56M
Total current assets 649.02M 585.31M 670.06M 372.83M 58.11M
Long term investments - - - - -
Net tangible assets - -1556.91300M -1648.10900M -696.52900M -290.21000M
Short term investments 4.48M - - - -
Net receivables 388.91M 359.15M 359.90M 176.64M 26.97M
Long term debt 2094.61M 2153.27M 2183.55M 776.57M 395.11M
Inventory 113.64M 127.75M 123.09M 58.78M 18.21M
Accounts payable 211.50M 222.50M 248.03M 191.04M 26.50M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - 4.78M -74.04400M -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 4.36M 8.69M -2.35400M -4.41100M 1.43M
Additional paid in capital - - - - -
Common stock total equity - - 0.01M 0.00900M 0.00724M
Preferred stock total equity - - 0.00100M 0.00100M -
Retained earnings total equity - - -43.02100M -199.19600M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 20.14M 22.41M 15.10M 16.48M 2.39M
Deferred long term asset charges - - - - -
Non current assets total 3970.80M 4634.28M 4580.43M 1453.44M 169.73M
Capital lease obligations 146.67M 140.56M 167.04M 22.28M 19.98M
Long term debt total - - 2183.55M 776.57M 395.34M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -411.17100M -1.12500M -815.70300M -84.86997M -248.86956M
Change to liabilities 0.00000M -83.38300M 136.63M 14.16M 2.69M
Total cashflows from investing activities -411.17100M -1824.75300M -815.70300M -84.87000M -96.28394M
Net borrowings -36.17600M 1395.57M 354.74M 185.66M 52.76M
Total cash from financing activities -66.05100M 1598.74M 643.15M -13.89300M 251.33M
Change to operating activities -101.48700M -108.69500M -10.76700M -9.55800M -0.87918M
Net income 73.13M 158.15M -58.71800M 12.24M 2.09M
Change in cash -103.35500M 49.66M 23.08M -0.87500M 0.83M
Begin period cash flow 149.63M 99.96M 76.88M 10.64M 0.12M
End period cash flow 46.27M 149.63M 99.96M 9.77M 0.95M
Total cash from operating activities 373.87M 275.68M 195.63M 60.42M 68.43M
Issuance of capital stock 0.00000M 278.85M 367.60M 145.00M 250.00M
Depreciation 351.18M 258.05M 82.44M 11.28M 47.88M
Other cashflows from investing activities - -1620.32000M -752.56700M -37.44900M -37.44900M
Dividends paid - 0.00000M 935.94M 82.45M 250.00M
Change to inventory -6.30000M -14.92000M -19.43400M -14.25900M 2.31M
Change to account receivables -0.20900M -29.69400M -29.51700M -11.81100M -22.04272M
Sale purchase of stock -13.99200M 277.28M -44.27300M -20.00000M 250.00M
Other cashflows from financing activities -18.39300M 2189.32M 1842.30M 91.95M 1.60M
Change to netincome 56.13M 3.35M 93.57M 28.38M 13.51M
Capital expenditures 391.42M 203.31M 39.76M 21.33M 9.95M
Change receivables - -29.69400M -29.51700M - -
Cash flows other operating - -26.07700M 82.77M - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - 49.66M 23.08M - -
Change in working capital -107.99600M -153.30900M 76.91M -18.18800M 0.43M
Stock based compensation 22.40M 25.32M 18.67M 11.07M -
Other non cash items 17.12M -34.92100M 97.43M 43.12M 65.91M
Free cash flow -17.55600M 72.37M 155.88M 39.09M 58.48M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AHCO
Adapthealth Corp		 0.03 0.31% 9.70 - 12.02 0.41 0.90 1.10 -16.7376
ABT
Abbott Laboratories		 -2.1 1.86% 110.55 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -7.27 1.99% 358.65 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -1.45 1.59% 89.89 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -1.94 2.70% 69.96 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

Adapthealth Corp

220 West Germantown Pike, Plymouth Meeting, PA, United States, 19462

Key Executives

Name Title Year Born
Mr. Stephen P. Griggs CEO & Director 1958
Mr. Joshua Parnes Pres & Director 1979
Mr. Jason A. Clemens C.F.A. CFO & Principal Accounting Officer 1979
Mr. Albert A. Prast Chief Technology Officer 1960
Mr. Daniel C. Bunting Chief Operating Officer of Field Operations 1962
Anton Hie VP of Investor Relations NA
Mr. Christopher J. Joyce Gen. Counsel & Sec. 1964
Ms. Wendy Russalesi Chief Compliance Officer NA
Leila Vargas Exec. VP of Sales & Marketing NA
Joel Mills Chief People Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.